feed,title,long_url,short_url
Benzinga,BridgeBio Pharma's BBP-418 Muscular Dystrophy Study Moves Forward With Patient Dosing,https://www.benzinga.com/general/biotech/21/02/19751887/bridgebio-pharmas-bbp-418-muscular-dystrophy-study-moves-forward-with-patient-dosing,https://j.mp/2Nq3Chr
